RU95104501ARU95104501/14ARU95104501ARU95104501ARU 95104501 ARU95104501 ARU 95104501ARU 95104501/14 ARU95104501/14 ARU 95104501/14ARU 95104501 ARU95104501 ARU 95104501ARU 95104501 ARU95104501 ARU 95104501A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Л.И. КирилловfiledCriticalЛ.И. Кириллов
Priority to RU95104501/14ApriorityCriticalpatent/RU95104501A/en
Publication of RU95104501ApublicationCriticalpatent/RU95104501A/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
FIELD: medicine. SUBSTANCE: antilymphoglob is 0.002-0.003% solution of anti-T-lymphocyte gamma-globulin and 2% solution of poly-4-vinylpyridine. Agent can be used for prevention of the transplanted organs and tissues detachment, treatment patients with AIDS and activation of protective function of organism immunological system. Agent does not contain blood serum albumin that causes allergic reactions and does not decrease protective function of organism immunological system. Solution of anti-T-lymphocyte gamma-globulin (concentration is 0.002-0.003%) is administrated intravenously at dose 1-4 ml/1 kg weight at rate 20 drops/min with simultaneous intravenous administration of 2% solution of poly-4-vinylpyridine at rate 20 drops/min (1 ml/1 kg weight). The repeated course - in 2 months. The amount of the administrated antilymphocyte globulin depends on the aim of gamma-globulin administration. EFFECT: enhanced effectiveness of agent.
Claims (1)
Антилимфоглоб представляет 0,002-0,003% раствор анти-Т-лимфоцитарного гамма-глобулина и 2% раствор поли-4-винилпиридина. Предназначен для предупреждения отторжения пересаженных органов и тканей, лечения больных СПИДом и активизации защитной функции иммунологической системы организма. Отличается тем, что не содержит сывороточного альбумина крови, вызывающего аллергические реакции, и не понижает защитной функции иммунологической системы организма. 0,002-0,003% раствор анти-Т-лимфоцитарного гамма-глобулина вводится внутривенно по 1-4 мл на 1 кг веса по 20 кап. в мин одновременным введением внутривенно 2%-ного раствора поли-4-винилпиридина по 20 кап. в мин по 1 мл на 1 кг веса. Повторный курс через 2 мес. Количество введения антилимероцитарного глобулина зависит от того, с какой целью гамма-глобулин вводится.Antilimphoglob is a 0.002-0.003% solution of anti-T-lymphocytic gamma globulin and a 2% solution of poly-4-vinylpyridine. Designed to prevent rejection of transplanted organs and tissues, treat AIDS patients and enhance the protective function of the body's immunological system. It differs in that it does not contain serum albumin of the blood, which causes allergic reactions, and does not lower the protective function of the body's immunological system. 0.002-0.003% solution of anti-T-lymphocytic gamma globulin is administered intravenously in 1-4 ml per 1 kg of body weight in 20 drops. per minute by simultaneous intravenous administration of a 2% solution of poly-4-vinylpyridine in 20 drops. per minute, 1 ml per 1 kg of weight. Repeated course after 2 months. The amount of administration of antilimerocytic globulin depends on the purpose for which gamma globulin is administered.
Attempted prevention of blast crisis in chronic myeloid leukemia by the use of pulsed doses of cytosine arabinoside and cis-chloronitrosurea during the course of busulfan-maintained remission